Initial group of patients have received Saphnelo in a phase 3 trial evaluating lupus nephritis

Updated Date: Thu, 19 May 2022 00:00:00 EDT

Updated Date: Thu, 19 May 2022 00:00:00 EDT

A synthesized antibiotic derived from computer models of bacterial gene products appears to neutralize even drug-resistant bacteria. The […]

The health crisis for migrants crossing the Darién Gap is getting worse as the number of people crossing […]

It was a breath of fresh air to read Cox and Fritz’s description of how language shapes doctors’ […]

Sunday would normally be a day of peace, but this weekend it was anything but. The case of […]

The world of prediabetes, where no one can hear you screenI remember those joyous early years after it […]

Approval provides another step forward in transforming multiple myeloma outcomes and eliminating the disease

Libtayo has been approved for adults when curative surgery or radiation is not appropriate